Open Access
J Extra Corpor Technol
Volume 38, Number 1, March 2006
Page(s) 22 - 26
Published online 15 March 2006
  1. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. N Eng J Med. 1981;304:497–503. [CrossRef] [PubMed] [Google Scholar]
  2. Svennevig JL, Geiran OR, Karsen H, et al. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator. J Thorac Cardiovasc Surg. 1993;106:466–72. [CrossRef] [Google Scholar]
  3. Edmunds LH. Blood-surface interactions during cardiopulmonary bypass. J Card Surg. 1993;8:404–10. [CrossRef] [PubMed] [Google Scholar]
  4. Allen SM. Leukocyte depletion in cardiothoracic surgery. Perfusion. 1996;11:270–7. [CrossRef] [PubMed] [Google Scholar]
  5. Hill GE, Pohorecki R, Alonso A, Rennard SI, Robbins RA. Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass. Anesth Analg. 1996;83:696–700. [CrossRef] [PubMed] [Google Scholar]
  6. Hill GE, Alonso A, Spurzem RJR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 1995;110:1658–62. [CrossRef] [Google Scholar]
  7. Takaori M, Fukui A, Kimura K, et al. Hemostatic mechanism associated with aprotinin during and after extracorporeal circulation for cardiac and great vessel surgery. Masui. 1995;44:1661–6. [PubMed] [Google Scholar]
  8. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990;76:1680–7. [CrossRef] [PubMed] [Google Scholar]
  9. Mannucci L, Gerometta PS, Mussoni L, et al. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin. Thromb Haemost. 1995;73:356–61. [CrossRef] [PubMed] [Google Scholar]
  10. Stammers AH, Rasmussen CA, Kratz JM. Hemorrhagic effects of post cardiopulmonary bypass fibrinolysis. J Extra Corpor Technol. 1993;25:133–9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  11. Cameron D. Initiation of white cell activation during cardiopulmonary bypass: Cytokines and receptors. J Cardiovasc Pharmacol. 1996;27(suppl 1):S1–5. [CrossRef] [PubMed] [Google Scholar]
  12. Suhara H, Sawa Y, Nishimura M, et al. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg. 2001;71:1602–8. [Google Scholar]
  13. de Vroege R, van Oeveren W, van Klarenbosch J, et al. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. Anesth Analg. 2004;98:1586–94. [CrossRef] [PubMed] [Google Scholar]
  14. Zhang K, Hu Z, Yang Y, Huang R, Fan H, Sun Z. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass. J Huazhong Univ Sci Technolog Med Sci. 2003;23:403–6. [CrossRef] [PubMed] [Google Scholar]
  15. Kazaz H, Oto O, Sariosmanoglu N, Hazan E. The effects of heparin coated circuits on pulmonary injury. A clinical study. J Cardiovasc Surg (Torino). 2003;44:611–5. [PubMed] [Google Scholar]
  16. Ikuta T, Fujii H, Shibata T, et al. A new poly-2-methoxy-ethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg. 2004;77:1678–83. [CrossRef] [Google Scholar]
  17. Gunaydin S, Farsak B, Kocakulak M, Sari T, Yorgancioglu C, Zorlutuna Y. Clinical performance and biocompatibility of poly (2-methoxyethylacrylate)-coated extracorporeal circuits. Ann Thorac Surg. 2002;74:819–24. [CrossRef] [Google Scholar]
  18. Noguchi M, Eishi K, Tada S, et al. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 2003;9:22–8. [Google Scholar]
  19. Ninomiya M, Miyaji K, Takamoto S. Influence of PMEA-coated bypass circuits on perioperative inflammatory response. Ann Thorac Surg. 2003;75:913–7. [CrossRef] [Google Scholar]
  20. Zimmermann AK, Aebert H, Reiz A, et al. Hemocompatibility of PMEA coated oxygenators used for extracorporeal circulation procedures. ASAIO J. 2004;50:193–9. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.